Key Drivers
- Profitability Strength
- Cash Flow Quality
- Liquidity Watch
AIAI Summary
BSX has shifted from a clean mid-teens growth story to a near-term reset, with WATCHMAN softness and U.S. EP competition now the key swing factors, so the stock is only attractive if upcoming updates confirm this is temporary rather than the start of a more durable share-loss phase.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Profitability Strength
- •Cash Flow Quality
- •Liquidity Watch
BSX shows strong profitability and cash generation with moderate leverage, but tighter liquidity and a heavy intangible-asset balance temper the story, especially at a still-premium valuation.
Price Behavior
Key Price Behavior Insights:
- •Higher highs
- •Dip buying
- •Stretched momentum
BSX remains in a strong short-term uptrend, but after an ~18% rise over the last month it looks overbought, so bulls should watch $49.30 support and $51.83 resistance for signs of either continuation or a pullback.
~18% rally over the last month with overbought momentum
Sentiment & News
Key News Insights:
- •Q2 Beat
- •WATCHMAN Slowdown
- •Valuation Reset
Boston Scientific beat Q2 expectations and still shows solid core growth, but guidance cuts tied to WATCHMAN and U.S. EP competition are pressuring sentiment despite valuation support.
The stock may stay range-bound near term as investors weigh strong underlying growth against segment-specific headwinds and a lowered outlook
Similar Companies in Healthcare
Other companies in the same sector with AI ratings